|
PCNP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.68689999996619E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.007780E-04 |
| Normal-vs-Stage2 |
1.593120E-04 |
| Normal-vs-Stage3 |
1.9211399999941E-05 |
| Normal-vs-Stage4 |
4.17139999999705E-05 |
| Stage1-vs-Stage2 |
2.353600E-01 |
| Stage1-vs-Stage3 |
2.335200E-01 |
| Stage1-vs-Stage4 |
2.485000E-01 |
| Stage2-vs-Stage3 |
7.772200E-01 |
| Stage2-vs-Stage4 |
9.419200E-01 |
| Stage3-vs-Stage4 |
8.270200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.16350000001209E-06 |
| Normal-vs-AfricanAmerican |
7.803600E-02 |
| Normal-vs-Asian |
1.961580E-03 |
| Caucasian-vs-AfricanAmerican |
1.631820E-01 |
| Caucasian-vs-Asian |
5.326400E-01 |
| AfricanAmerican-vs-Asian |
4.134400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.88929999994847E-06 |
| Normal-vs-Female |
2.47099999999278E-05 |
| Male-vs-Female |
4.267600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.988500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.61450999999202E-05 |
| Normal-vs-Age(61-80Yrs) |
2.0174000000539E-06 |
| Normal-vs-Age(81-100Yrs) |
8.784200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.139600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.174380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.197800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.953000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.262400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.350400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.581600E-01 |
| Classical-VS-Follicular |
1.952960E-01 |
| Classical-VS-Other |
9.576400E-01 |
| Classical-VS-Normal |
1.171910E-04 |
| Tall-VS-Follicular |
9.207000E-01 |
| Tall-VS-Other |
5.328200E-01 |
| Tall-VS-Normal |
5.638100E-04 |
| Follicular-VS-Other |
6.566200E-01 |
| Follicular-VS-Normal |
2.638100E-04 |
| Other-VS-Normal |
1.718990E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49100000002012E-06 |
| Normal-vs-N1 |
9.64620000000194E-05 |
| N0-vs-N1 |
8.921200E-01 |
|
|
